Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» INT230-6
INT230-6
Intensity Therapeutics signs clinical collaboration agreement with Bristol Myers Squibb for advanced solid tumors
Pharmaceutical Business Review
Wed, 04/15/20 - 10:47 am
Bristol-Myers Squibb
Intensity Therapeutics
INT230-6
Yervoy
solid tumors